Hara Levy, MD, MMSc, professor, Division of Pulmonology and Sleep Medicine, was recently awarded a three-year, $375,000 grant from the Rosenau Family Research Foundation for the project “Enriching CF Newborn Screening Outcomes through a Precision Personalized Medicine Strategy.” Cystic fibrosis (CF) is considered a genetic disorder, although there are variations in disease presentation due to multiple genes influencing individual characteristics that remain to be defined. Levy’s team seeks to elucidate some of the molecular mechanisms that might explain why children diagnosed with cystic fibrosis (CF) early through newborn screening (NBS) have such wide variations in susceptibility to respiratory infections, long-term outcomes, and responses to treatment. Researchers expect their studies will help identify personalized therapeutic targets to limit CF lung disease progression caused by chronic airway infections. Stephen Meyn, MD, PhD, Division of Genetics and Metabolism, and Qiongshi Lu, PhD, in the Department of Biostatistics and Medical Informatics, will serve as co-investigators on this project. The project began on November 1, 2024. Read more about this work.